Resources

European Union GDPR—Pharmaceutical Company

Advised pharmaceutical company on all aspects of compliance with the GDPR, including gap analysis, policy and procedure development, and vendor and other third party contract revisions.

Firm Highlights

Publication/Podcast

CMS Proposes to Make Lump-Sum Payments to Hospitals for Underpayments for Drugs Purchased Through the 340B Program During 2018-2022

Last week CMS issued its anticipated proposed rule to implement the Supreme Court’s decision last year which ruled that CMS’ reduction in Medicare payments for Part B outpatient drugs purchased through the 340B program...

Publication/Podcast

Telehealth and the Evolving Landscape of Medicare Requirements

Telehealth is an important and growing part of healthcare delivery that a wide range of patients and healthcare providers have come to rely on for access to care and continuity of treatment. Telehealth took...

Publication/Podcast

Don’t Wait – CMS Expects Hospitals to Take Action on Informed Consent for Certain Exams and Procedures

Hospitals should not delay in reviewing and revising their surgical informed consent forms and policies. On April 1, 2024, the Centers for Medicare & Medicaid Services (“CMS”) issued new guidance regarding informed consent for...

Publication/Podcast

Speaking of Health Law Podcast with David Lazarus

Verrill Partner David Lazarus was a recent guest on the AHLA’s Speaking of Health Law podcast. The episode featured industry leaders discussing some of the key takeaways of the Schutte v. SuperValu, Inc. case...

News

Verrill Adds Three Experienced Attorneys to the Firm’s Healthcare and Life Sciences Industry Group

News

Verrill Recognized Nationally for Health Care, Land Use and Zoning, Commercial Litigation, Real Estate, and Trust & Estates by Best Lawyers®

News

Verrill Dana Adds Healthcare Trio in Boston

Contact Verrill at (855) 307 0700